Digoxin

別名:NSC 95100, 12β-Hydroxydigitoxin

Digoxin is a classical Na,K-ATPase inhibitor, with selectivity for the α2β3 isoform over the common α1β1 isoform, used in the treatment of atrial fibrillation and heart failure.This product is a hazardous chemical (acute toxicity/flammable/skin corrosive). Please use it while wearing a protective face mask, gloves, and clothing.

Digoxin化学構造

CAS No. 20830-75-5

サイズ 価格(税別) 在庫状況
JPY 22000 国内在庫あり
JPY 44500 国内在庫あり

代表番号: 045-509-1970|電子メール:[email protected]
よく尋ねられる質問

文献中Selleckの製品使用例(13)

製品安全説明書

現在のバッチを見る: 純度: 99.61%
99.61

Digoxin関連製品

シグナル伝達経路

ATPase阻害剤の選択性比較

Cell Data

Cell Lines Assay Type Concentration Incubation Time 活性情報 PMID
Hs578Bst Cytotoxicity assay 40 uM 72 hrs Cytotoxicity against human Hs578Bst cells at 40 uM after 72 hrs by CellTiter-Glo assay relative to untreated control, IC50=47.7μM 22316168
HeLa Function assay 150 nM 24 hrs Inhibition of Na(+)/K(+) ATPase in human HeLa cells at 150 nM after 24 hrs by immunoblotting 26122772
HeLa Function assay 150 nM 24 hrs Inhibition of Na(+)/K(+) ATPase in human HeLa cells at 150 nM after 24 hrs by immunoblotting 26122772
HeLa Function assay 150 nM 24 hrs Inhibition of Na(+)/K(+) ATPase in human HeLa cells at 150 nM after 24 hrs by immunoblotting 26122772
HeLa Function assay 150 nM 24 hrs Inhibition of Na(+)/K(+) ATPase in human HeLa cells at 150 nM after 24 hrs by immunoblotting 26122772
HeLa Function assay 150 nM 24 hrs Inhibition of Na(+)/K(+) ATPase in human HeLa cells at 150 nM after 24 hrs by immunoblotting 26122772
HeLa Function assay 150 nM 24 hrs Inhibition of Na(+)/K(+) ATPase in human HeLa cells at 150 nM after 24 hrs by immunoblotting 26122772
HeLa Function assay 150 nM 24 hrs Inhibition of Na(+)/K(+) ATPase in human HeLa cells at 150 nM after 24 hrs by immunoblotting 26122772
HeLa Function assay 150 nM 24 hrs Inhibition of Na(+)/K(+) ATPase in human HeLa cells at 150 nM after 24 hrs by immunoblotting 26122772
DU145 Function assay 50 uM 5 hrs Inhibition of Na+/K+ ATPase pump in human DU145 cells assessed as increase in intracellular calcium level at 50 uM measured after 5 hrs by Fura-2/AM dye based fluorescence assay 31120251
DU145 Function assay 50 uM 5 hrs Inhibition of Na+/K+ ATPase pump in human DU145 cells assessed as increase in intracellular calcium level at 50 uM measured after 5 hrs by Fura-2/AM dye based fluorescence assay 31120251
DU145 Function assay 50 uM 5 hrs Inhibition of Na+/K+ ATPase pump in human DU145 cells assessed as increase in intracellular calcium level at 50 uM measured after 5 hrs by Fura-2/AM dye based fluorescence assay 31120251
DU145 Function assay 50 uM 5 hrs Inhibition of Na+/K+ ATPase pump in human DU145 cells assessed as increase in intracellular calcium level at 50 uM measured after 5 hrs by Fura-2/AM dye based fluorescence assay 31120251
DU145 Function assay 50 uM 5 hrs Inhibition of Na+/K+ ATPase pump in human DU145 cells assessed as increase in intracellular calcium level at 50 uM measured after 5 hrs by Fura-2/AM dye based fluorescence assay 31120251
DU145 Function assay 50 uM 5 hrs Inhibition of Na+/K+ ATPase pump in human DU145 cells assessed as increase in intracellular calcium level at 50 uM measured after 5 hrs by Fura-2/AM dye based fluorescence assay 31120251
DU145 Function assay 50 uM 5 hrs Inhibition of Na+/K+ ATPase pump in human DU145 cells assessed as increase in intracellular calcium level at 50 uM measured after 5 hrs by Fura-2/AM dye based fluorescence assay 31120251
DU145 Function assay 50 uM 5 hrs Inhibition of Na+/K+ ATPase pump in human DU145 cells assessed as increase in intracellular calcium level at 50 uM measured after 5 hrs by Fura-2/AM dye based fluorescence assay 31120251
human hepatocytes Function assay 0.05 to 10 uM Drug uptake in sandwich-cultured human hepatocytes at 0.05 to 10 uM at 37 degC by Michaelis-Menten kinetics/scintillation spectroscopy, Km=2.39 μM 20926619
HCT116 Cytotoxicity assay 72 hrs Cytotoxicity against human HCT116 cells after 72 hrs by FMCA method, IC50=0.27μM 19894733
CC20 Cytotoxicity assay 72 hrs Cytotoxicity against human CC20 cells after 72 hrs by FMCA method, IC50=0.24μM 19894733
colon cancer Cytotoxicity assay 72 hrs Cytotoxicity against human colon cancer cells after 72 hrs by FMCA method, IC50=0.1μM 19894733
UACC62 Cytotoxicity assay 48 hrs Cytotoxicity against human UACC62 cells after 48 hrs by SRB assay, IC50=0.0295μM 16309315
MCF7 Cytotoxicity assay 48 hrs Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay, IC50=0.0241μM 16309315
TK10 Cytotoxicity assay 48 hrs Cytotoxicity against human TK10 cells after 48 hrs by SRB assay, IC50=0.0146μM 16309315
HT-29 Cytotoxicity assay 72 hrs Cytotoxicity against human HT-29 cells after 72 hrs by FMCA method, IC50=1.4μM 19894733
Hs578Bst Cytotoxicity assay 72 hrs Cytotoxicity against human Hs578Bst cells after 72 hrs by CellTiter-Glo assay, IC50=0.04μM 22316168
Hs578T Cytotoxicity assay 72 hrs Cytotoxicity against human Hs578T cells after 72 hrs by CellTiter-Glo assay, IC50=0.251μM 22316168
T47D Cytotoxicity assay 72 hrs Cytotoxicity against human T47D cells after 72 hrs by CellTiter-Glo assay, IC50=0.66μM 22316168
SK-BR-3 Cytotoxicity assay 72 hrs Cytotoxicity against human SK-BR-3 cells after 72 hrs by CellTiter-Glo assay, IC50=1.08μM 22316168
MCF7 Cytotoxicity assay 72 hrs Cytotoxicity against human MCF7 cells after 72 hrs by CellTiter-Glo assay, IC50=4.7μM 22316168
Hs683 Cytotoxicity assay 3 days Cytotoxicity against human Hs683 cells after 3 days by MTT assay, IC50=0.04μM 23706005
A549 Cytotoxicity assay 3 days Cytotoxicity against human A549 cells after 3 days by MTT assay, IC50=0.05μM 23706005
PC3 Cytotoxicity assay 3 days Cytotoxicity against human PC3 cells after 3 days by MTT assay, IC50=0.075μM 23706005
U373 Cytotoxicity assay 3 days Cytotoxicity against human U373 cells after 3 days by MTT assay, IC50=0.146μM 23706005
SK-MEL-28 Cytotoxicity assay 3 days Cytotoxicity against human SK-MEL-28 cells after 3 days by MTT assay, IC50=0.266μM 23706005
MCF7 Cytotoxicity assay 3 days Cytotoxicity against human MCF7 cells after 3 days by MTT assay, IC50=0.426μM 23706005
RKO-AS45-1 Cytotoxicity assay 48 hrs Cytotoxicity against human RKO-AS45-1 cells after 48 hrs by MTT assay, IC50=0.42μM 26122772
HeLa Cytotoxicity assay 48 hrs Cytotoxicity against human HeLa cells after 48 hrs by MTT assay, IC50=2.2μM 26122772
Kasumi-1 Cytotoxicity assay 48 hrs Cytotoxicity against human Kasumi-1 cells incubated for 48 hrs by MTS assay, IC50=0.093μM 27983842
MV4-11 Cytotoxicity assay 48 hrs Cytotoxicity against human MV4-11 cells incubated for 48 hrs by MTS assay, IC50=0.111μM 27983842
HT-29 Cytotoxicity assay 72 hrs Cytotoxicity against human HT-29 cells incubated for 72 hrs by SRB assay, IC50=0.38μM 27983842
H1299 Cytotoxicity assay 24 hrs Cytotoxicity against human H1299 cells incubated for 24 hrs by MTT assay, IC50=0.46μM 27983842
CCD-112CoN Cytotoxicity assay 72 hrs Cytotoxicity against human CCD-112CoN cells incubated for 72 hrs, IC50=2.4μM 27983842
HeLa Function assay Inhibition of mitosis in human HeLa cells by imaging analysis 18066055
HeLa Cytotoxicity assay Cytotoxicity against human HeLa cells assessed as inhibition of DNA replication by imaging analysis 18066055
K562 Cytotoxicity assay Cytotoxicity against human K562 cells by XTT assay, IC50=0.0282μM 16309315
MDCK Function assay TP_TRANSPORTER: cell accumulation in OATP4C1-expressing MDCK cells, Km=8μM 14993604
MDCK Function assay TP_TRANSPORTER: cell accumulation in OATP4C1-expressing MDCK cells, Km=7.8μM 14993604
LLC-PK1 Function assay TP_TRANSPORTER: uptake in Oatp2-expressing LLC-PK1 cells, Km=0.279μM 11883641
LLC-PK1 Function assay TP_TRANSPORTER: uptake in Oatp2-expressing LLC-PK1 cells, Km=1.07μM 11792694
LLC-PK1 Function assay TP_TRANSPORTER: inhibition of Taurocholate uptake in Oatp2-expressing LLC-PK1 cells, Ki=0.58μM 11792694
High Five (BTI-TN5B1-4) Function assay TP_TRANSPORTER: ATP hydrolysis in membrane fraction from High Five (BTI-TN5B1-4) cells, Km=25.9μM 11785684
LLC-PK1 Function assay TP_TRANSPORTER: inhibition of E217betaG uptake in Oatp2-expressing LLC-PK1 cells, Ki=0.037μM 11408557
rat hepatocytes Function assay Drug uptake in rat hepatocytes, Km=0.18 μM 20926619
CHO Function assay pIC50 values for sodium fluorescein (10 uM) uptake in OATP1B1-transfected CHO cells, IC50=3.23594μM 23571415
CHO Function assay pIC50 values for sodium fluorescein (10 uM) uptake in OATP1B3-transfected CHO cells, IC50=13.1826μM 23571415
Drosophila Schneider cells Function assay Antagonist activity at transactivation domain of RORgammat (unknown origin) expressed in Drosophila Schneider cells co-expressing Gal4-DNA binding domain, IC50=2μM 24040486
Drosophila Schneider cells Function assay Antagonist activity at transactivation domain of RORgammat (unknown origin) expressed in Drosophila Schneider cells co-expressing Gal4-DNA binding domain, IC50=2μM 24040486
他の多くの細胞株試験データをご覧になる場合はこちらをクリックして下さい

生物活性

製品説明 Digoxin is a classical Na,K-ATPase inhibitor, with selectivity for the α2β3 isoform over the common α1β1 isoform, used in the treatment of atrial fibrillation and heart failure.This product is a hazardous chemical (acute toxicity/flammable/skin corrosive). Please use it while wearing a protective face mask, gloves, and clothing.
Targets
Na,K-ATPase α2β3 [1] Na,K-ATPase α2β1 [1] Na,K-ATPase α1β1 [1]
42.8 nM(Ki) 58.7 nM(Ki) 268 nM(Ki)

化学情報

分子量 780.94 化学式

C41H64O14

CAS No. 20830-75-5 SDF Download Digoxin SDFをダウンロードする
Smiles CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
保管

In vitro
Batch:

DMSO : 100 mg/mL ( (128.05 mM); 吸湿したDMSOは溶解度を減少させます。新しいDMSOをご使用ください。)

Water : Insoluble

Ethanol : Insoluble

モル濃度計算器

in vivo
Batch:

Add solvents to the product individually and in order.

投与溶液組成計算機

実験計算

モル濃度計算器

質量 濃度 体積 分子量

投与溶液組成計算機(クリア溶液)

ステップ1:実験データを入力してください。(実験操作によるロスを考慮し、動物数を1匹分多くして計算・調製することを推奨します)

mg/kg g μL

ステップ2:投与溶媒の組成を入力してください。(ロット毎に適した溶解組成が異なる場合があります。詳細については弊社までお問い合わせください)

% DMSO % % Tween 80 % ddH2O
%DMSO %

計算結果:

投与溶媒濃度: mg/ml;

DMSOストック溶液調製方法: mg 試薬を μL DMSOに溶解する(濃度 mg/mL, 注:濃度が当該ロットのDMSO溶解度を超える場合はご連絡ください。 )

投与溶媒調製方法:Take μL DMSOストック溶液に μL PEG300,を加え、完全溶解後μL Tween 80,を加えて完全溶解させた後 μL ddH2O,を加え完全に溶解させます。

投与溶媒調製方法:μL DMSOストック溶液に μL Corn oil,を加え、完全溶解。

注意:1.ストック溶液に沈殿、混濁などがないことをご確認ください;
2.順番通りに溶剤を加えてください。次のステップに進む前に溶液に沈殿、混濁などがないことを確認してから加えてください。ボルテックス、ソニケーション、水浴加熱など物理的な方法で溶解を早めることは可能です。

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

大学・企業名を記入してください
名前を記入してください
電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
お問い合わせ内容をご入力ください
Tags: Digoxinを買う | Digoxin ic50 | Digoxin供給者 | Digoxinを購入する | Digoxin費用 | Digoxin生産者 | オーダーDigoxin | Digoxin化学構造 | Digoxin分子量 | Digoxin代理店